Literature DB >> 17262985

The tangled story of Alois Alzheimer.

N Zilka1, M Novak.   

Abstract

In 1907, Bavarian psychiatrist Alois Alzheimer, who is considered to be a founding father of neuropathology, was first to describe the main neuropathologic characteristics of the peculiar disease in the brain of a woman showing progressive dementia when she was in her early 50s. Using a newly developed Bielschowsky's silver staining method, Alzheimer observed degenerating neurons with bundles of fibrils (neurofibrillary tangles) and miliary foci of silver-staining deposits scattered over the cortex (senile plaques). In 1910 Emil Kraepelin (Alois Alzheimer's superior) coined the term "Alzheimer's disease" to distinguish the presenile form of dementia from the more common senile variant. Alzheimer's findings were followed up, and soon a number of reports of similar cases appeared in the literature. During the time, both pathological hallmarks of Alzheimer's disease became the gold standard for post-mortem diagnosis of the disease. One hundred years later, dementia of Alzheimer's type is considered to be one of the most devastating illnesses of old age. Despite intensive research the cause of the disease still remains elusive (Fig. 2, Ref. 17).

Entities:  

Mesh:

Year:  2006        PMID: 17262985

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  7 in total

1.  Regional vulnerability in Alzheimer's disease: The role of cell-autonomous and transneuronal processes.

Authors:  Diana Acosta; Fontasha Powell; Yize Zhao; Ashish Raj
Journal:  Alzheimers Dement       Date:  2018-01-04       Impact factor: 21.566

Review 2.  Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories.

Authors:  Gayle Helane Doherty
Journal:  Neurosci Bull       Date:  2011-12       Impact factor: 5.203

3.  Role of Tau Acetylation in Alzheimer's Disease and Chronic Traumatic Encephalopathy: The Way Forward for Successful Treatment.

Authors:  Brandon Lucke-Wold; Kay Seidel; Rub Udo; Bennet Omalu; Mark Ornstein; Richard Nolan; Charles Rosen; Joel Ross
Journal:  J Neurol Neurosurg       Date:  2017-12-07

Review 4.  Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease.

Authors:  Touqeer Ahmed; Saadia Zahid; Aamra Mahboob; Syeda Mehpara Farhat
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

5.  Early diagnosis and treatment of Alzheimer's disease: new definitions and challenges.

Authors:  Marcos Pais; Luana Martinez; Octávio Ribeiro; Júlia Loureiro; Romel Fernandez; Leandro Valiengo; Paulo Canineu; Florindo Stella; Leda Talib; Marcia Radanovic; Orestes V Forlenza
Journal:  Braz J Psychiatry       Date:  2020-01-24       Impact factor: 2.697

6.  N-Acetyl Cysteine Supplement Minimize Tau Expression and Neuronal Loss in Animal Model of Alzheimer's Disease.

Authors:  Teresa Joy; Muddanna S Rao; Sampath Madhyastha
Journal:  Brain Sci       Date:  2018-10-11

7.  Mechanism of Neural Regeneration Induced by Natural Product LY01 in the 5×FAD Mouse Model of Alzheimer's Disease.

Authors:  Xiao-Wan Li; Yang-Yang Lu; Shu-Yao Zhang; Ning-Ning Sai; Yu-Yan Fan; Yong Cheng; Qing-Shan Liu
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.